Publications by authors named "Bergkamp S"

Objectives: In childhood-onset SLE (cSLE), patients have an increased risk of premature atherosclerosis. The pathophysiological mechanisms for this premature atherosclerosis are not yet completely understood, but besides traditional risk factors, the endothelium plays a major role. The first aim of this study was to measure levels of SLE-associated markers involved in endothelial cell (EC) function and lipids in a cSLE cohort longitudinally in comparison with healthy controls (HC).

View Article and Find Full Text PDF
Article Synopsis
  • Juvenile idiopathic arthritis (JIA) is a chronic autoimmune condition in children that can lead to joint issues and often co-occurs with uveitis; adalimumab is a targeted treatment for both conditions.
  • The study aimed to analyze the pharmacokinetics (PK) of adalimumab in JIA patients by comparing existing PK models and creating a new model specific to this demographic.
  • Results from 50 JIA patients indicated that body weight, antidrug antibodies, and other factors influenced adalimumab clearance, with a recommended clearance rate established for more personalized treatment approaches.
View Article and Find Full Text PDF
Article Synopsis
  • The study aims to validate the childhood lupus low disease activity state (cLLDAS) in children with systemic lupus erythematosus (cSLE) by comparing the time to reach adult LLDAS (aLLDAS) and identifying predictors for maintaining cLLDAS.
  • A cohort of 50 cSLE patients was analyzed over a median follow-up of 3.1 years, showing that while all patients reached aLLDAS and cLLDAS at least once, 58% maintained cLLDAS for at least half of the follow-up, with significant negative predictors identified.
  • The study concludes that the time to reach cLLDAS differs from aLL
View Article and Find Full Text PDF

Objectives: Rituximab (RTX), used for treatment in paediatric immune-mediated diseases, can lead to hypogammaglobulinaemia and thus to an increased risk of infection, but data on these adverse effects in children are scarce. We aimed to describe the pharmacodynamics of RTX by time to B cell repopulation in paediatric immune-mediated diseases and to assess whether low post-RTX immunoglobulin levels were associated with frequency and severity of infections.

Methods: Data of children with autoimmune diseases (AID), immune dysregulation (ID), haematological diseases (HD) and renal diseases (RD), including immunoglobulin levels pre-/post-RTX and occurrence of infections, who had received RTX at our centre were retrospectively collected.

View Article and Find Full Text PDF

Background: Nailfold video capillaroscopy (NVC) is a simple, non-invasive diagnostic tool but studies with normal values for capillary density in healthy children are rare. Ethnic background seems to play a role in capillary density; however, this is not well substantiated yet. In this work, we set out to evaluate influence of ethnic background/skin pigmentation and age on capillary density reading in healthy children.

View Article and Find Full Text PDF

Objectives: To perform a systematic literature review and meta-analysis on endothelial cell (EC) markers that are involved and dysregulated in systemic lupus erythematosus (SLE) in relation to disease activity, as EC dysregulation plays a major role in the development of premature atherosclerosis in SLE.

Methods: Search terms were entered into Embase, MEDLINE, Web of Science, Google Scholar and Cochrane. Inclusion criteria were 1) studies published after 2000 reporting measurements of EC markers in serum and/or plasma of SLE patients (diagnosed according to ACR/SLICC criteria), 2) English language peer reviewed articles, and 3) disease activity measurement.

View Article and Find Full Text PDF

Objectives: To observe if capillary patterns in childhood-onset SLE (cSLE) change over time and find associations between a capillary scleroderma pattern with disease activity, damage or scleroderma-like features.

Methods: Clinical and (yearly) capillaroscopy data from a longitudinal cohort of patients with cSLE (minimum of four Systemic Lupus International Collaborating Clinics (SLICC) criteria, onset <18 years) were analysed. Disease activity was measured by Systemic Lupus Erythematosus Activity Index (SLEDAI) and disease damage by SLICC Damage Index.

View Article and Find Full Text PDF

Objectives: To assess the (structural and functional) characteristics of the microvascular and dermal status in juvenile localised scleroderma (jLoS), using novel non-invasive standardised research tools commonly used in adult systemic sclerosis (SSc).

Methods: Ten consecutive patients with a confirmed jLoS diagnosis were studied cross-sectionally in this two-centre case series. For each patient, the most prominent lesion (i.

View Article and Find Full Text PDF

Objectives: In systemic lupus erythematosus (SLE), it is necessary to obtain biomarkers that predict cardiovascular complications due to premature atherosclerosis, which is related to endothelial dysfunction. Nailfold capillary abnormalities might be a biomarker for endothelial dysfunction. In adults and children with SLE, nailfold capillary haemorrhages have shown to be significantly correlated with disease activity.

View Article and Find Full Text PDF
Article Synopsis
  • Anti-TNF drugs have significantly improved outcomes for children with juvenile idiopathic arthritis (JIA), but there's limited evidence on how serum drug levels and anti-drug antibodies (ADAbs) affect treatment decisions.
  • A study analyzed the serum anti-TNF drug levels and ADAbs in 65 children with JIA, finding that nearly 45% of the measurements influenced treatment decisions for about 65% of the patients.
  • Results indicated that many patients had varying drug levels and that those with ADAbs typically had undetectable drug levels, highlighting the need for more specific therapeutic ranges and pharmacokinetic studies for these medications in children.
View Article and Find Full Text PDF

Objectives: For selection of high-risk systemic lupus erythematosus (SLE) patients it is necessary to obtain indicators of disease severity that predict disease damage. As in systemic sclerosis, nailfold capillary abnormalities could be such a biomarker in SLE. The primary objective of this cross-sectional study is to describe capillary abnormalities in childhood-onset SLE (cSLE) cohort (onset < 18 years) and compare them with matched healthy controls.

View Article and Find Full Text PDF